Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Soleno Therapeutics (SLNO)
Soleno Therapeutics Analyst Ratings
Soleno Therapeutics (SLNO) Receives a Buy From Stifel Nicolaus
Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target
Soleno Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Biomea Fusion (BMEA) and Soleno Therapeutics (SLNO)
Analysts' Top Healthcare Picks: Soleno Therapeutics (SLNO), Optinose (OPTN)
Soleno Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics (SLNO), Merck & Company (MRK) and Tenet Healthcare (THC)
Soleno Therapeutics Analyst Ratings
Soleno Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics (SLNO), Agilon Health (AGL) and Integer Holdings (ITGR)
Soleno Therapeutics Analyst Ratings
Oppenheimer Adjusts Soleno Therapeutics Price Target to $44 From $39, Maintains Outperform Rating
Cantor Fitzgerald Maintains Overweight on Soleno Therapeutics, Raises Price Target to $35
Soleno Therapeutics Analyst Ratings
Oppenheimer Raises Soleno Therapeutics Price Target to $14 Form $8, Maintains Outperform Rating
Cantor Fitzgerald Reiterates Overweight on Soleno Therapeutics, Maintains $19 Price Target
Soleno Therapeutics Analyst Ratings
Cantor Fitzgerald Initiates Coverage On Soleno Therapeutics With Overweight Rating, Announces Price Target of $19
No Data